Does SITAGLIPTIN Cause Acute hepatic failure? 21 Reports in FDA Database

Q: Does SITAGLIPTIN cause Acute hepatic failure?

21 reports of Acute hepatic failure have been filed with the FDA for SITAGLIPTIN, representing 0.1% of all SITAGLIPTIN adverse event reports.

Q: How dangerous is Acute hepatic failure from SITAGLIPTIN?

Of 21 reports, 19 (90.5%) resulted in death and 8 required hospitalization.

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Acute hepatic failure have been filed in association with SITAGLIPTIN (JANUVIA). This represents 0.1% of all adverse event reports for SITAGLIPTIN.

Reports of Acute hepatic failure with SITAGLIPTIN

0.1%

of all SITAGLIPTIN reports

Deaths

Hospitalizations

How Dangerous Is Acute hepatic failure From SITAGLIPTIN?

Of the 21 reports, 19 (90.5%) resulted in death, 8 (38.1%) required hospitalization, and 4 (19.0%) were considered life-threatening.

Is Acute hepatic failure Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for SITAGLIPTIN. However, 21 reports have been filed with the FAERS database.

What Other Side Effects Does SITAGLIPTIN Cause?

Blood glucose increased (1,427) Pancreatic carcinoma (1,142) Product dose omission issue (1,125) Drug ineffective (1,057) No adverse event (994) Nausea (936) Pancreatitis (922)</